ANKRD17 and hepatocellular carcinoma: This suggests that ANKRD17 promotes the pro-metastatic transcription of Yap1 and pro-survival AKT phosphorylation during HCC metastatic progression by dysregulating the HIPPO and PTEN signaling pathways, respectively.